Combination Therapy with Copanlisib and Niraparib in Patients with Recurrent Endometrial and Ovarian Cancer (COPANIRA): Efficacy, Toxicity, and Translational Insights
Allison L. Brodsky(The University of Texas MD Anderson Cancer Center), Shannon N. Westin(The University of Texas MD Anderson Cancer Center)
Cited by 0
Related Papers
Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer
|Annals of Oncology|2024|123
Role of Indocyanine Green in Sentinel Node Mapping in Gynecologic Cancer: Is Fluorescence Imaging the New Standard?
|Journal of Minimally Invasive Gynecology|2015|58